The WHO calls for increased policy focus on neurological disorders like Alzheimer’s disease, an indication that has seen ...
Pfizer's Tukysa could become the first update to the maintenance regimen for HER2-positive breast cancer in over a decade if ...
BioCryst Pharmaceuticals has signed a definitive agreement to buy Astria Therapeutics with a mix of cash and stock ...
Goldman Sachs has secured the top spot as the leading financial adviser in mergers and acquisitions (M&A) based on deal value ...
Nabla Bio has entered a new multi-year research collaboration with Takeda to advance AI-driven design of protein therapeutics ...
Kirkland & Ellis has secured the foremost position as a legal adviser in the mergers and acquisitions (M&A) sector in terms ...
The FDA has approved AbbVie’s supplemental new drug application for Rinvoq (upadacitinib) to treat inflammatory bowel disease ...
Just a year after emerging from stealth with a nearly half a billion dollars, Kailera Therapeutics has reached another ...
Clinical research organizations (CROs) have transformed into major strategic partners for biotechnology and pharmaceutical ...
The latest amendment, which has been endorsed by Congress, could be the Act’s catalyst after a year in legislative limbo.
A spike in licensing of candidates developed in China this year is a sign of the country’s transition in the global pharma ...